Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants

We are collaborating with other national regulatory authorities to align the requirements for evaluating, authorizing and post-market surveillance of variant COVID-19 vaccines as much as possible.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2022-07-28

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data